(Q43466099)

23 November 2017

title

Anti-hepatitis B virus effects of dehydrocheilanthifoline from Corydalis saxicola (English)

1 reference

23 November 2017

1 reference

Fan-Li Zeng

1

1 reference

23 November 2017

Yang-Fei Xiang

2

1 reference

23 November 2017

Zhen-Ran Liang

3

1 reference

23 November 2017

Xiao Wang

4

1 reference

23 November 2017

Dan-E Huang

5

1 reference

23 November 2017

Sui-Nan Zhu

6

1 reference

23 November 2017

Min-Min Li

7

1 reference

23 November 2017

De-Po Yang

8

1 reference

23 November 2017

Dong-Mei Wang

9

1 reference

23 November 2017

Yi-Fei Wang

10

1 reference

23 November 2017

publication date

1 January 2013

1 reference

The American Journal of Chinese Medicine

23 November 2017

published in

1 reference

23 November 2017

volume

41

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

119-130

1 reference

Comparison of anti-hepatitis B virus activities of lamivudine and clevudine by a quantitative assay

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Suppression of mRNA accumulation by the duck hepatitis B virus reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Simultaneous determination of eight bioactive alkaloids in Corydalis saxicola by high-performance liquid chromatography coupled with diode array detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Screening of 25 compounds isolated from Phyllanthus species for anti‐human hepatitis B virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

BJ-B11, a novel Hsp90 inhibitor, induces apoptosis in human chronic myeloid leukemia K562 cells through the mitochondria-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Assessment of liver fibrosis in co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Antiviral activities of extracts isolated from Terminalis chebula Retz., Sanguisorba officinalis L., Rubus coreanus Miq. and Rheum palmatum L. against hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Current treatment of chronic hepatitis B: benefits and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Hepatitis B virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Effect of oxymatrine on the replication cycle of hepatitis B virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

Traditional Chinese medicine syndrome distribution in chronic hepatitis B populations: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X13500092

10.1142/S0192415X13500092

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference